dr. litton on the impact of parp inhibitors in breast cancer
Published 5 years ago • 133 plays • Length 1:27Download video MP4
Download video MP3
Similar videos
-
9:21
dr. litton on activity of talazoparib in advanced brca1/2 breast cancer
-
0:58
dr. litton on the embraca trial in advanced brca1/2 breast cancer
-
3:31
distinguishing between parp inhibitors in breast cancer
-
2:02
dr. litton on a study of neoadjuvant talazoparib for patients with brca-mutated tnbc
-
1:16
parp inhibitors improve outcomes, qol in breast cancer
-
0:56
dr. muss on the role of parp inhibitors in breast cancer
-
1:34
litton: the promise of parp inhibitors
-
0:45
parp inhibitors versus standard of care treatment in breast cancer
-
1:16
dr. litton on genetic testing in breast cancer
-
1:17
dr. traina on parp inhibition in brca-mutated breast cancer
-
7:42
parp inhibitors in other subtypes of breast cancer
-
1:10
dr. tripathy on impact of olaparib approval in brca-positive breast cancer
-
1:32
dr. chang discusses the use of parp inhibitors in prostate cancer
-
1:13
addressing the role of parp inhibitors in different breast cancer settings
-
2:35
dr. monk on choosing between parp inhibitors in ovarian cancer
-
2:08
dr. lorusso on parp inhibitors in triple-negative breast cancer
-
3:58
brca breast cancer: the advent of parp inhibitors
-
7:04
testing for brca germline mutations in the clinic and the mechanism of action of parp inhibitors
-
2:47
talave: induction talazoparib with parp inhibition in breast cancer